Description: SOHM Inc. is a pharmaceutical manufacturer that produces and markets generic drugs for all major treatment categories. The Company obtained a direct manufacturing license under Current Good Manufacturing Practice and initiated processes to be compliant with World Health Organization regulations to produce generic as well as OTC pharmaceuticals. The Company’s manufacturing facility, located in India, enables low production costs without compromising quality. SOHM develops, manufactures and markets generic pharmaceuticals in various dosage forms, including tablets and capsules, creams and topicals, ointments, liquids and injectables. The Company has licenses to manufacture 30 products and approximately 300 generic drugs and product formulations for distribution. The Company focuses on emerging markets in Africa, Latin America, Southeast Asia and the European Union. The Company’s global headquarters is located in North America and it has offices in China, India and the United Kingdom.
Home Page: www.sohm.com
4740 Green River Road
Corona,
CA
92880
United States
Phone:
714-522-6700
Officers
| Name | Title |
|---|---|
| Mr. Shailesh Shah | Chairman, CEO, Pres, CEO of US, India & Global Ops and Pres of US, India & Global Ops |
| Ms. Swati Shah | VP, Sec., Treasurer and Director |
| Mr. Sanjiv Bosamia | Chief Exec. Officer of Dermatology and Cosmeceutical Division |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.9133 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 145 |